Pigott TA - Search Results

1

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.

Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL. Grady TA, et al. Among authors: pigott ta. Am J Psychiatry. 1993 May;150(5):819-21. doi: 10.1176/ajp.150.5.819. Am J Psychiatry. 1993. PMID: 8480832 Clinical Trial.

2

A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder.

Rubenstein CS, Pigott TA, L'Heureux F, Hill JL, Murphy DL. Rubenstein CS, et al. Among authors: pigott ta. J Clin Psychiatry. 1992 Sep;53(9):309-14. J Clin Psychiatry. 1992. PMID: 1517192

3

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.

Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL. Pigott TA, et al. J Clin Psychopharmacol. 1992 Feb;12(1):11-8. doi: 10.1097/00001573-199202000-00003. J Clin Psychopharmacol. 1992. PMID: 1552034 Clinical Trial.

4

A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder.

Pigott TA, L'Heureux F, Rubenstein CS, Bernstein SE, Hill JL, Murphy DL. Pigott TA, et al. J Clin Psychopharmacol. 1992 Jun;12(3):156-62. J Clin Psychopharmacol. 1992. PMID: 1629380 Clinical Trial.

5

Symptoms of eating disorders in patients with obsessive-compulsive disorder.

Pigott TA, Altemus M, Rubenstein CS, Hill JL, Bihari K, L'Heureux F, Bernstein S, Murphy DL. Pigott TA, et al. Am J Psychiatry. 1991 Nov;148(11):1552-7. doi: 10.1176/ajp.148.11.1552. Am J Psychiatry. 1991. PMID: 1928472

6

Seasonal variation in obsessive-compulsive disorder: preliminary experience with light treatment.

Yoney TH, Pigott TA, L'Heureux F, Rosenthal NE. Yoney TH, et al. Among authors: pigott ta. Am J Psychiatry. 1991 Dec;148(12):1727-9. doi: 10.1176/ajp.148.12.1727. Am J Psychiatry. 1991. PMID: 1957938

7

Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.

Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL. Pato MT, et al. Among authors: pigott ta. Am J Psychiatry. 1991 Jan;148(1):127-9. doi: 10.1176/ajp.148.1.127. Am J Psychiatry. 1991. PMID: 1984696 Clinical Trial.

8

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.

Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL. Pigott TA, et al. Biol Psychiatry. 1991 Mar 1;29(5):418-26. doi: 10.1016/0006-3223(91)90264-m. Biol Psychiatry. 1991. PMID: 2018816 Clinical Trial.

9

A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.

Murphy DL, Pigott TA. Murphy DL, et al. Among authors: pigott ta. J Clin Psychiatry. 1990 Apr;51 Suppl:53-8; discussion 59-60. J Clin Psychiatry. 1990. PMID: 2139026 Review.

10

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.

Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL. Pigott TA, et al. Arch Gen Psychiatry. 1990 Oct;47(10):926-32. doi: 10.1001/archpsyc.1990.01810220042005. Arch Gen Psychiatry. 1990. PMID: 2222131 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters